Close

Twist Bioscience Corporation (TWST) Tops Q1 EPS by 2c, Revenues Beat; Offers FY21 Revenue Mid-Point Guidance Below Consensus

Go back to Twist Bioscience Corporation (TWST) Tops Q1 EPS by 2c, Revenues Beat; Offers FY21 Revenue Mid-Point Guidance Below Consensus
(NASDAQ: TWST) Delayed: 31.50 --0 (-0%)
Previous Close $31.50    52 Week High
Open $31.50    52 Week Low
Day High $31.50    P/E N/A 
Day Low $31.50    EPS
Volume 505